| Financial Year |
March 31 2023 |
| Monetary Funds |
472,028,128.80 |
| Held-for-trading Financial Assets |
665,753.33 |
| Notes Receivable |
-- |
| Accounts Receivable |
258,836,087.81 |
| Advances to Suppliers |
6,012,099.23 |
| Other Receivables |
4,274,852.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,195,910.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,249,738.69 |
| Total Current Assets |
767,262,570.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,065,786.54 |
| Investment Properties |
-- |
| Fixed Assetes |
204,487,031.59 |
| Under-construction Projects |
10,241,589.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,583,904.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,176,586.53 |
| Deferred Income Tax Assets |
3,777,645.85 |
| Other Non-Current Assets |
99,988,138.99 |
| Sub-Total of Non-Current Assets |
402,296,555.66 |
| Total Assets |
1,169,559,126.44 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
499,966.72 |
| Notes Payable |
31,532,509.60 |
| Accounts Payable |
67,151,238.21 |
| Accounts Received In Advance |
76,452.61 |
| Employee Compensation Payable |
4,570,286.91 |
| Taxes Payable |
5,511,604.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,412,672.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
203,741.01 |
| Other Current Liabilities |
40,495.58 |
| Sub-Total of Current Liabilities |
123,040,896.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
41,446.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
791,315.42 |
| Total Liabilities |
123,832,212.02 |
| Paid-In Capital(Or Share Stock) |
240,000,000.00 |
| Capital Surplus |
439,860,676.00 |
| Surplus Reserve |
33,745,024.47 |
| LESS:Treasury Stock |
40,336,479.79 |
| Undistributed Profits |
372,049,797.09 |
| Minority Stockholder's Interest |
407,896.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,045,319,017.77 |
| Owner's Equity（Stockholder's Equity） |
1,045,726,914.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,169,559,126.44 |
